Published

The Effects of Psychedelics on Neuronal Physiology.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Annual review of physiology
Date: 2024-02-12
Source: PubMed
DOI: 10.1146/annurev-physiol-042022-020923
PubMed: 37931171

Authors

Hatzipantelis CJ Olson DE

Watch author

Derived topics and classifications

psilocybin Neuroplasticity Mechanism of Action Receptor Pharmacology Safety Other

Citation graph

0 referenced DOIs found in stored source metadata. 2 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Psilocybin Decreases Preference for Large Rewards Accompanied by Increased Activity of Parvalbumin Neurons With Perineuronal Nets in the Medial Prefrontal Cortex2026-06-01 Advanced Delivery Systems and Novel Psilocin Derivatives for Enhanced Therapeutic Applications2024-12-12

Related papers

Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelicsFrontiers in Psychiatry · 2024-11-06 Psychedelics and mental health: reimagining care through science, insight, and compassion.Frontiers in pharmacology · 2025-01-01 Harnessing neuroplasticity with psychoplastogens: the essential role of psychotherapy in psychedelic treatment optimizationFrontiers in Psychiatry · 2025-04-08 Direct Comparison of Altered States of Consciousness Induced by LSD, Psilocybin, and DMT in a Randomized, Placebo-controlled, Cross-over Trial in Healthy Participants (LPD-Study)ClinicalTrials.gov · 2025-03-27 Acute Analgesic Effects of DMT on Experimentally Induced Acute Nociceptive Pain, Hyperalgesia and Allodynia in Healthy ParticipantsClinicalTrials.gov · 2026-04-02 Nicotinoyl-Tryptamine Derivatives as Potential Dual-Action Prodrugs for NAD⁺ Enhancement and NeuroprotectionZenodo (CERN European Organization for Nuclear Research) · 2026-03-01 Molecular Imaging Study of Harmine/DMT: a Basic Research ApproachClinicalTrials.gov · 2025-03-19 Mindfulness and Psychedelics: A Combined Neurophenomenological and Pharmacological Approach to the Characterization of Mindfulness States in Experienced MeditatorsClinicalTrials.gov · 2023-09-21